Health Canada’s approval of MAVIRET for acute HCV allows doctors to treat adults and children immediately, a key step toward the 2030 elimination goal.
Health Canada officially authorizes TNKase for treating acute ischemic stroke in adults. This pivotal approval introduces a faster, 5-second injection to emergency rooms nationwide.